Skip to content
value.today

Abbott Laboratories vs ViewRay

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Abbott Laboratories is the larger company by market value: $181.1 B against $4 M for ViewRay, 45277 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jul 30, 2023 for ViewRay). ViewRay's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
  • Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $70 M for ViewRay in the year to December 2021.
  • Abbott Laboratories made a net profit of $6.5 B, while ViewRay made a net loss of $110 M.
  • Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -157.1% for ViewRay.
  • Abbott Laboratories employs more people: 115,000 against 267 at ViewRay. Each employee brings in about $385,461 of revenue at Abbott Laboratories and $262,172 at ViewRay.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

039791181582020202120222023202420252026Abbott Laboratories 119ViewRay 1

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$11B$22B$33B$44B201720182019202020212022202320242025Abbott Laboratories $44B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbott Laboratories
ABT · #117 in the world
ViewRay
VRAY
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices
Founded18882004
Size
Market cap$181.1 B$4 M*
Revenue$44.3 B$70 M
Net income$6.5 B▲ best$-110 M
Employees115,000267
Valuation
P/E ratio38.5×—
Price to sales3.8×—
Price to book3.5×—
Free cash flow yield4.1%—
Profitability
Gross margin56.4%—
Operating margin18.2%—
Net margin14.7%—
Return on equity13.1%—
Return on invested capital11.2%—
Growth
Revenue growth5.7%—
Revenue growth, 3 years a year0.5%—
Earnings per share growth-51.3%—
Financial strength
Debt to equity0.3×—
Cash
Free cash flow margin16.7%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.8%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jul 2023

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Abbott Laboratories or ViewRay?

Abbott Laboratories is the larger company by market value: $181.1 B against $4 M for ViewRay, 45277 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jul 30, 2023 for ViewRay). ViewRay's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.

Which makes more money, Abbott Laboratories or ViewRay?

Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $70 M for ViewRay in the year to December 2021. Abbott Laboratories made a net profit of $6.5 B, while ViewRay made a net loss of $110 M.

Which is more profitable, Abbott Laboratories or ViewRay?

Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -157.1% for ViewRay.

Which has more employees, Abbott Laboratories or ViewRay?

Abbott Laboratories employs more people: 115,000 against 267 at ViewRay. Each employee brings in about $385,461 of revenue at Abbott Laboratories and $262,172 at ViewRay.

Sources#

Every figure on this page comes from these, with the date shown next to it.